Question 1

What is Neuraxpharm?

Accepted Answer

Neuraxpharm is a Entity.

Question 2

How often does Neuraxpharm appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Neuraxpharm first tracked by Ergen?

Accepted Answer

First tracked on Jan 13, 2026.

Question 4

When was Neuraxpharm last mentioned in news?

Accepted Answer

Last active on Mar 09, 2026.

Question 5

What is Neuraxpharm's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Neuraxpharm in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Neuraxpharm?

Accepted Answer

TG Therapeutics 2025 Earnings and BRIUMVI Data (Jan 13, 2026, 6 articles).

Question 8

How did the "TG Therapeutics 2025 Earnings and BRIUMVI Data" event impact Neuraxpharm?

Accepted Answer

Neuraxpharm is TG Therapeutics' ex-U.S. licensing partner, contributing to the global commercialization and approval of Ublituximab in several countries outside the United States.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.